ViroXis
Latest round
- Series A
Last raised
- Jan 2011
Total raised
- $3.3M
Investors
- 2
About ViroXis
ViroXis Corp.ViroXis Corp. was founded in 2006 and is headquartered in San Antonio, US. The company focuses on the sale of high-value domain names, facilitating a direct connection for businesses to establish their digital identity. ViroXis was acquired by Quintis (TFS Corporation) in June 2015, although financial terms were not disclosed.com offers a premium domain name that serves as an online address for businesses and individuals looking to establish a recognizable digital presence. The core product, a high-value domain, is designed to cater to a variety of end users including entrepreneurs, startups, and established companies seeking to enhance their brand visibility. This domain can function as a critical component for e-commerce platforms, informational websites, or any online service that requires a strong web identity. The primary end use cases include serving as a business's main website or as part of a digital marketing strategy to drive traffic and engagement.46 per month for 24 months. The transaction structure is straightforward, with customers typically engaging in a direct-to-consumer model where they purchase the domain either outright or via installment payments. This approach allows clients the flexibility to acquire the domain name without a substantial upfront investment. The company's revenue streams are complemented by a 30-day satisfaction guarantee, which enhances consumer confidence and facilitates transactions.As of June 2015, following its acquisition, ViroXis Corp. aims to leverage its resources to expand its portfolio of premium domain names and enhance its marketing strategies. The company is targeting growth in North America, Europe, and Asia, with plans for increased presence in these regions.80 mn will be utilized to support the development of new digital marketing tools and enhance customer engagement strategies.
Who invested in ViroXis
2 investors across 2 rounds
See all investors in ViroXis
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about ViroXis
Who invested in ViroXis?
ViroXis has 2 investors on record across 2 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has ViroXis raised?
ViroXis has raised 2 venture rounds. Sign up free to see how much each round raised and the total.
When did ViroXis last raise money?
ViroXis's most recent round on record is a Series A, in Jan 2011.
What does ViroXis do?
ViroXis is a pharmaceuticals company.
Where is ViroXis headquartered?
ViroXis is headquartered in San Antonio, US.
Which VCs invest in companies like ViroXis?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back pharmaceuticals companies at ViroXis's stage. Their profiles are linked below.
VCs backing pharmaceuticals startups at Series A
Raising like ViroXis? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.